# Prospective Observation of Cardiac Safety With Proteasome Inhibition

> **NCT02178579** · — · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Heart Failure
- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02178579
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2020-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02178579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02178579, "Prospective Observation of Cardiac Safety With Proteasome Inhibition". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02178579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*